News Image

In the world of growth stocks, NASDAQ:LNTH shines as a value proposition.

By Mill Chart

Last update: Oct 11, 2023

Discover LANTHEUS HOLDINGS INC (NASDAQ:LNTH), an undervalued growth gem identified by our stock screener. NASDAQ:LNTH is shining in terms of growth metrics, and it's also displaying strong financial health and profitability. What's more, it retains an appealing valuation. We'll break it down further.

Growth Analysis for NASDAQ:LNTH

A key component of ChartMill's stock assessment is the Growth Rating, which spans from 0 to 10. This rating evaluates diverse growth factors, such as EPS and revenue growth, considering both past performance and future projections. NASDAQ:LNTH has received a 8 out of 10:

  • The Earnings Per Share has grown by an impressive 145.21% over the past year.
  • The Earnings Per Share has been growing by 33.91% on average over the past years. This is a very strong growth
  • Looking at the last year, LNTH shows a very strong growth in Revenue. The Revenue has grown by 69.36%.
  • LNTH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.05% yearly.
  • LNTH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.39% yearly.
  • Based on estimates for the next years, LNTH will show a quite strong growth in Revenue. The Revenue will grow by 13.49% on average per year.

What does the Valuation looks like for NASDAQ:LNTH

ChartMill employs its own Valuation Rating system for all stocks. This score, ranging from 0 to 10, is determined by evaluating different valuation factors, including price to earnings and free cash flow, both in absolute terms and relative to the market and industry. NASDAQ:LNTH has earned a 8 for valuation:

  • 94.58% of the companies in the same industry are more expensive than LNTH, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of LNTH to the average of the S&P500 Index (25.88), we can say LNTH is valued slightly cheaper.
  • Based on the Price/Forward Earnings ratio of 11.30, the valuation of LNTH can be described as reasonable.
  • 96.55% of the companies in the same industry are more expensive than LNTH, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 18.97, LNTH is valued a bit cheaper.
  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LNTH indicates a somewhat cheap valuation: LNTH is cheaper than 77.34% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, LNTH is valued cheaply inside the industry as 95.07% of the companies are valued more expensively.
  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • LNTH has a very decent profitability rating, which may justify a higher PE ratio.
  • LNTH's earnings are expected to grow with 18.78% in the coming years. This may justify a more expensive valuation.

Deciphering NASDAQ:LNTH's Health Rating

ChartMill utilizes a Health Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of liquidity and solvency ratios, both in absolute terms and in comparison to industry peers. NASDAQ:LNTH has earned a 7 out of 10:

  • LNTH has an Altman-Z score of 5.35. This indicates that LNTH is financially healthy and has little risk of bankruptcy at the moment.
  • LNTH has a Altman-Z score of 5.35. This is amongst the best in the industry. LNTH outperforms 80.79% of its industry peers.
  • LNTH has a debt to FCF ratio of 2.29. This is a good value and a sign of high solvency as LNTH would need 2.29 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 2.29, LNTH belongs to the best of the industry, outperforming 92.61% of the companies in the same industry.
  • Even though the debt/equity ratio score it not favorable for LNTH, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
  • A Current Ratio of 4.88 indicates that LNTH has no problem at all paying its short term obligations.
  • LNTH's Current ratio of 4.88 is fine compared to the rest of the industry. LNTH outperforms 62.56% of its industry peers.
  • A Quick Ratio of 4.55 indicates that LNTH has no problem at all paying its short term obligations.
  • LNTH has a better Quick ratio (4.55) than 66.50% of its industry peers.

Profitability Analysis for NASDAQ:LNTH

Discover ChartMill's exclusive Profitability Rating, a proprietary metric that assesses stocks on a scale of 0 to 10. It takes into consideration various profitability ratios and margins, both in absolute terms and relative to industry peers. Notably, NASDAQ:LNTH has achieved a 6:

  • The Return On Assets of LNTH (2.49%) is better than 78.82% of its industry peers.
  • Looking at the Return On Equity, with a value of 6.04%, LNTH belongs to the top of the industry, outperforming 81.28% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 10.74%, LNTH belongs to the best of the industry, outperforming 92.61% of the companies in the same industry.
  • LNTH's Profit Margin of 2.97% is fine compared to the rest of the industry. LNTH outperforms 75.86% of its industry peers.
  • The Operating Margin of LNTH (14.30%) is better than 86.70% of its industry peers.
  • With a decent Gross Margin value of 63.18%, LNTH is doing good in the industry, outperforming 66.50% of the companies in the same industry.
  • LNTH's Gross Margin has improved in the last couple of years.

Every day, new Affordable Growth stocks can be found on ChartMill in our Affordable Growth screener.

Check the latest full fundamental report of LNTH for a complete fundamental analysis.

Keep in mind

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.

Back

LANTHEUS HOLDINGS INC

NASDAQ:LNTH (4/19/2024, 7:01:46 PM)

After market: 63.81 0 (0%)

63.81

+1.48 (+2.37%)

LNTH News

News Image2 days ago - Lantheus Holdings, Inc.Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time
News Image2 days ago - Lantheus Holdings, Inc.Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time

BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference...

News Image3 days ago - ChartmillNASDAQ:LNTH: a strong growth stock preparing for the next leg up?.

LANTHEUS HOLDINGS INC (NASDAQ:LNTH) qualifies as a high growth stock and is consolidating.

News Image8 days ago - The Motley Fool2 Magnificent Stocks You Probably Never Heard Of

You might not have heard of these stocks, but they're worth putting on your radar.

News Image9 days ago - ChartmillInvestors should take notice of NASDAQ:LNTH—it offers a great deal for the fundamentals it presents.

LANTHEUS HOLDINGS INC (NASDAQ:LNTH), an undervalued stock with good fundamentals.

News Image10 days ago - InvestorPlaceWall Street Favorites: 3 Russell 2000 Stocks With Strong Buy Ratings for April 2024

Explore three Russell 2000 stocks with strong buy ratings for April 2024, offering high growth potential and lower valuations.

News Image18 days ago - Market News VideoInteresting LNTH Put And Call Options For May 17th
News Image18 days ago - ChartmillNASDAQ:LNTH is showing good growth, while it is not too expensive.

Investors seeking growth at a reasonable cost should explore NASDAQ:LNTH.

News Imagea month ago - InvestorPlaceThe 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024

Wager on these top undervalued mid-cap stocks, effectively blending growth and value, with a remarkable broader-market performance in 2023.

News Image2 months ago - Lantheus Holdings, Inc.Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024
News Image2 months ago - Lantheus Holdings, Inc.Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024

BEDFORD, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company...

News Image2 months ago - Lantheus Holdings, Inc.Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients

DEFINITY is the #1 utilized ultrasound enhancing agent in the U.S. for patients with suboptimal echocardiograms

LNTH Links
Follow us for more